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There is a growing demand for alternative fabrication approaches to develop tissues and 
organs as conventional techniques are not capable of fabricating constructs with required 
structural, mechanical, and biological complexity. 3D bioprinting offers great potential to 
fabricate highly complex constructs with precise control of structure, mechanics, and 
biological matter [i.e., cells and extracellular matrix (ECM) components]. 3D bioprinting 
is an additive manufacturing approach that utilizes a “bioink” to fabricate devices and 
scaffolds in a layer-by-layer manner. 3D bioprinting allows printing of a cell suspension 
into a tissue construct with or without a scaffold support. The most common bioinks are 
cell-laden hydrogels, decellulerized ECM-based solutions, and cell suspensions. In this 
mini review, a brief description and comparison of the bioprinting methods, including 
extrusion-based, droplet-based, and laser-based bioprinting, with particular focus on 
bioink design requirements are presented. We also present the current state of the art in 
bioink design including the challenges and future directions.
Keywords: additive manufacturing, biofabrication, tissue engineering, regenerative medicine, hydrogel, cell 
printing, extracellular matrix
inTRODUCTiOn
Tissue engineering is a multidisciplinary field currently focused on two major areas: (i) developing 
new methods to repair, regenerate, and replace damaged tissues and organs and (ii) creating in vitro 
tissue models to better understand tissue development, disease development, and progression and 
to develop and screen drugs (Langer and Vacanti, 1993; Griffith and Naughton, 2002; Benam et al., 
2015; Tibbitt et al., 2015; Nguyen et al., 2016; Zhang et al., 2016). Despite recent advances in tissue 
engineering, there is a continuous lack of tissues and organs for transplantation and a shortage 
for tissue models for drug discovery and testing (Bajaj et  al., 2014). Conventional techniques, 
such as porogen-leaching, injection molding, and electrospinning, are generally recognized as the 
bottleneck due to limited control over scaffold architecture, composition, pore shape, size, and 
distribution (Murphy and Atala, 2014; Groen et al., 2016; Shafiee and Atala, 2016). 3D bioprinting 
enables fabrication of scaffolds, devices, and tissue models with high complexity (Murphy and 
Atala, 2014; Mandrycky et al., 2016; Ozbolat et al., 2016, 2017; Shafiee and Atala, 2016). 3D print-
ing allows construction of tissues from commonly used medical images (such as X-ray, magnetic 
resonance imaging, and computerized tomography scan) using computer-aided design. Custom 
and patient-specific design, on-demand fabrication, high structural complexity, low-cost, and 
FigURe 1 | 3D bioprinting techniques for bioprinting of tissues and organs. Figure reproduced with permission from Miller and Burdick (2016). Copyright 
2016, American Chemical Society.
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high-efficiency are some of the major advantages of 3D printing 
making it very attractive for medicine (Guillemot et  al., 2010; 
Guvendiren et al., 2016).
3D bioprinting is a technology to fabricate constructs from 
living cells with or without a carrier material in a layer-by-layer 
manner (Dababneh and Ozbolat, 2014; Murphy and Atala, 2014; 
Mandrycky et al., 2016; Shafiee and Atala, 2016; Cui et al., 2017). 
The material that is printed is referred to as a “bioink,” which can 
be defined as an ink formulation that allows printing of living 
cells. Here, we would like to note that many of the biomaterial 
ink formulations are not suitable for cell printing. For instance, 
polycaprolactone (PCL) and poly(lactic acid) (PLA) are the most 
widely used biomaterials in 3D printing. However, they could 
only be printed at elevated temperatures in the form of a polymer 
melt or when dissolved in organic solvents as a polymer solution. 
Therefore, they are not considered as bioinks in this review, as 
both approaches are not suitable for live cell printing (Jose et al., 
2016; Munaz et al., 2016). In this paper, we discuss the most com-
monly used bioinks, including cell-laden hydrogels, extracellular 
matrix (ECM)-based solutions, and cell suspensions (Levato 
et al., 2014; Adam et al., 2016; Guvendiren et al., 2016; Panwar 
and Tan, 2016), and give the current state of the art in bioink 
design with challenges and future directions. A brief description 
and comparison of the bioprinting methods with particular focus 
on bioink design requirements are also given.
3D BiOPRinTing TeCHnOLOgieS
3D bioprinting process should be relatively mild and cell friendly 
as it is required to allow cell printing (Ozbolat et al., 2016, 2017). 
This requirement limits the number of 3D printing techniques 
that are suitable for bioprinting (Figure  1). It is important to 
note that the 3D printing technology determines the require-
ments for printability of a material, and not all of the 3D printing 
technologies are suitable for bioprinting. Currently available 
3D printing technologies allow a wide range of materials to be 
printed using diverse ink formulations (Guvendiren et al., 2016). 
Fused deposition modeling (FDM) is an extrusion-based print-
ing and utilizes synthetic thermoplastics and their composites 
with ceramics and metals (Turner et  al., 2014). For FDM, the 
form of ink material is a filament, and it is extruded at elevated 
temperatures (140–250°C) in melt state, which eliminates FDM 
as an option for bioprinting. Direct ink writing (DIW) is also an 
extrusion-based printing and allows extrusion of high viscosity 
solutions, hydrogels, and colloidal suspensions (Ozbolat and 
Hospodiuk, 2016). DIW allows printing of cell suspensions 
and/or aggregates with or without a carrier. Inkjet printing is 
another technology for cell printing. The processing principle 
is deposition of polymeric solutions, colloidal suspensions, 
and cell suspensions, with relatively low viscosities [<10  cP 
(mPa⋅s)] at relatively high shear rates (105–106 s−1) in the form 
droplets (~50 μm in diameter) (Mironov et al., 2003; Wilson and 
Boland, 2003a,b; Nakamura et al., 2005; Gudapati et al., 2016). 
As compared to extrusion-based bioprinters, inkjet bioprinters 
are not readily available, yet there are commercially available 
inkjet print heads that are suitable for bioprinting (Nishiyama 
et  al., 2008; Choi et  al., 2011). Selective laser sintering utilizes 
metals, ceramics, polymers, and composites in powder form 
(10–150 µm in diameter) and is not suitable for bioprinting. In 
this technique, a directed laser beam locally melts either directly 
the powder or a polymeric binder onto the bed surface (Shirazi 
et al., 2015). Layers of fresh powder are continuously supplied 
after each layer is created. Stereolithography (SLA) requires a 
viscous photocurable polymer solution or a prepolymer, which 
is exposed to a directed light (such as UV or laser) to spatially 
cross-link the solution (Skoog et al., 2014). SLA could potentially 
be considered for printing live cells as long as a cell-laden pre-
polymer formulation is used and the photocuring takes place in 
a mild, cell friendly condition, which are the two major issues for 
SLA in bioprinting (Elomaa et al., 2015; Wang et al., 2015; Morris 
et al., 2017). When 3D printing technologies are considered for 
bioprinting, the most commonly used technologies are DIW and 
inkjet printing (Ozbolat et al., 2016, 2017). In addition to these 
technologies laser-induced forward transfer (LIFT) is also shown 
to be suitable for bioprinting (Barron et al., 2004a,b; Ringeisen 
et al., 2004; Hopp et al., 2005; Doraiswamy et al., 2006; Koch et al., 
2010). In this technique, ink solution is coated onto a glass slide 
and coated with a laser absorption layer (metal or a metal oxide). 
Laser is directed to the laser absorption layer with an ablation 
spot size between 40 and 100  µm in diameter (Barron et  al., 
2004a,b; Koch et al., 2010) creating a local pressure to eject the 
ink layer to the substrate.
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BiOinK DeSign
The ideal bioink formulation should satisfy certain material 
and biological requirements. Material properties are print-
ability, mechanics, degradation, and functionalizability. 
Biological requirements mainly include biocompatibility, 
cytocompatilibilty, and bioactivity. When material properties 
are considered, printability is the most important parameter. 
Printability comprises two parts: (i) the processability of 
the bioink formulation and (ii) the print fidelity associated 
with the mechanical strength of the printed construct to 
self-sustain a 3D structure post-printing. Depending on the 
printing process, printability could potentially involve solu-
tion viscosity, surface tension, and cross-linking properties. 
Viscosity is a crucial parameter for a bioink formulation as it 
affects both the print fidelity and cell encapsulation efficiency. 
High viscosity polymer solutions are less likely to flow easily 
so that the printed structure could hold its shape at longer 
times post-printing. However, they require higher pressures 
to flow, limiting the gage size and smallest achievable print 
size (mainly for DIW). In this regard, Tirella et  al. (2009) 
investigated the processing window for alginate hydrogels 
using pressure-assisted microfabrication (DIW technique). 
They successfully developed a 3D phase diagram showing the 
interplay between bioink viscosity, print velocity, and applied 
pressure to obtain high print fidelity (Tirella et al., 2009). The 
bioink formulation is preferred to have a tunable viscosity to 
be compatible with different bioprinters. For instance, bioinks 
for inkjet or droplet-based bioprinters have viscosity values 
close to 10  mPa⋅s (Gudapati et  al., 2016); the viscosity of 
bioinks for extrusion-based DIW bioprinting ranges from 30 
to 6 × 107 mPa⋅s (Hölzl et al., 2016; Ozbolat et al., 2016, 2017); 
for laser-assisted bioprinting, the bioink viscosity is in the 
range of 1–300 mPa⋅s (Guillotin et al., 2010; Hölzl et al., 2016). 
For high viscosity bioinks used in extrusion and droplet-based 
print, the shear-thinning characteristic is desired to compen-
sate for the high shear stress associated with high viscosity. The 
overall mechanics, i.e., achievable stiffness, is important not 
only to create self-supporting constructs but also to control 
and direct cellular behavior. Degradation is important for 
the functional integration of the printed construct in vivo by 
enabling cells to gradually replace the construct with their 
ECM. Both the bioink and the degradation products should 
not contain materials that induce inflammatory host response 
when implanted. Functionalizability is required to incorporate 
biochemical cues, i.e., bioactivity, to direct cellular behavior, 
such as adhesion, migration, and differentiation. In addition 
to biocompatibility and cytocompatibility, high cell viability, 
both prior- and post-printing, is crucial for the ink formula-
tion. In addition to bioink design, a recent study showed the 
importance of the print substrate for live cell inkjet printing. In 
this work, computational and experimental studies confirmed 
that the stiffness of the print substrate directly influences the 
impact forces acting on the droplet, which affects the overall 
cell survival (Tirella et  al., 2011). Below we will discuss the 
commonly used bioinks including current state of the art in 
ink design.
CURRenTLY AvAiLABLe BiOinKS
The most commonly used bioinks for tissue and organ printing 
are cell-laden hydrogels, decellularized extracellular matrix 
(dECM)-based solutions, and cell suspensions (Figure  2). 
Cell-laden hydrogels are particularly attractive due to their 
tunable properties and their ability to recapitulate the cellular 
microenvironment (Fedorovich et al., 2007). ECM-based bioink 
formulations or decellulerized tissue inks are an emerging field 
due to their inherent bioactivity and ease of formulation into a 
printable bioink (Pati et al., 2014). Cell suspension inks based on 
cell aggregates are a viable option to create scaffold-free biological 
constructs (Forgacs and Foty, 2004; Marga et al., 2007).
Cell-Laden Hydrogels
Cell-laden hydrogels are the most commonly used bioinks as they 
can be easily formulated for extrusion-based (DIW), droplet-
based (inkjet), and laser-based (SLA and LIFT) bioprinting tech-
nologies. Cell-laden hydrogel bioink formulations utilize natural 
hydrogels such as agarose, alginate, chitosan, collagen, gelatin, 
fibrin, and hyaluronic acid (HA), as well as synthetic hydrogels 
such as pluronic (poloxamer) and poly(ethylene glycol) (PEG), or 
blends of both. Natural hydrogels offer inherent bioactivity except 
for agarose and alginate and display a structural resemblance to 
ECM. For instance, fibrin and collagen hydrogels with inherent 
filamentous structure display strain-stiffening property, mimick-
ing the non-linear elastic behavior of the soft tissues in our body 
(Gardel et al., 2004; Storm et al., 2005). Synthetic hydrogels permit 
but do not promote cellular function, yet there are many ways to 
tether bioactive cues into synthetic hydrogels (Guvendiren and 
Burdick, 2013). When compared to natural hydrogels, synthetic 
hydrogels generally offer tunable mechanical properties. Many 
natural polymers (such as gelatin and HA) have functionaliz-
able backbone side chains enabling them to be functionalized 
with chemical moieties to induce cross-linking (chemical- and/
or photo-cross-linking) or additional bioactivity (Burdick and 
Prestwich, 2011). Blends of synthetic and natural polymers 
have been used to develop mechanically tunable hydrogels with 
user-defined bioactivity. Finally, the mechanical properties and/
or bioactivity can also be tuned by incorporating small amounts 
of nanoparticles into bioink formulation (Ribeiro et al., 2015).
Usually, all hydrogel bioink formulations require printing of 
a polymer solution followed by subsequent cross-linking. This 
requires a highly viscous polymer solution (polymer wt% >3%) 
and rapid cross-linking to develop self-supporting structures. 
There are two forms of cross-linking: physical and chemical 
cross-linking. Physical cross-linking is a non-chemical approach 
that utilizes hydrophobic interactions, ionic interactions, and 
hydrogen bonding. Chemical cross-linking relies on the forma-
tion of covalent bonds, which could be a radical polymerization 
(such as photo-cross-linking) or Michael-type addition reaction. 
The chemically cross-linked hydrogels form a mechanically robust 
network as compared to the physically cross-linked hydrogels, 
which is particularly important for the stem cell behavior includ-
ing differentiation (Huebsch et al., 2010; Khetan et al., 2013).
Pluronic and PEG are the most common synthetic polymers 
for bioprinting. Pluronic, a poloxamer-based triblock copolymer 
FigURe 2 | (i) 3D printed constructs in various forms (a,b) using poly(ethylene glycol)–alginate–nanoclay hydrogels. Red food dye was incorporated into some of the 
bioink formulations for visibility. Live/dead assay of cells (c) in a collagen infused mesh from (b). Reprinted with permission from Hong et al. (2015). Copyright 2015, 
John Wiley and Sons. (ii) Tissue construct printed from decellularized extracellular matrix (dECM) (a), SEM images of hybrid constructs from dECM supported with 
polycaprolactone framework (b,c), and fluorescent images of cells (d). Scale bars are 5 mm for (a), 400 µm for (b,c), and 100 µm for (d). Adapted with permission 
from Pati et al. (2014). Copyright 2014, Nature Publishing Group. (iii) Cell aggregate (500-µm average diameter) configurations in simulations (A,B,K,L) and 
experiments. C–J correspond to cell aggregates embedded in a neurogel with RGD fragments (C,D) and collagen gels of concentration 1.0 mg/ml (E,F), 1.2 mg/ml 
(G,H), and 1.7 mg/ml (I,J). Figure adapted with permission from Jakab et al. (2004). Copyright 2004, National Academy of Sciences.
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composed of two hydrophobic groups between a water-soluble 
group, has been widely used in extrusion-based bioprinting as 
it gels at room temperature but flows at temperatures below 
10°C. However, it is not very stable and erodes within hours. 
Thus, it is generally used as a supporting material (Kang et al., 
2016). Lewis Lab took an advantage of this property and printed 
pluronic within a photopolymerizable hydrogel to create micro 
channels (Wu et  al., 2011). Müller et  al. (2015) developed an 
acrylated pluronic to create UV cross-linked stable gels post-
printing. The most common forms of PEG for bioinks are 
PEG-diacrylate (PEG-DA) and PEG-methacrylate, which are 
suitable for extrusion-based, droplet-based, and laser-based 
printing technologies (Cui et al., 2012; Hribar et al., 2014; Wüst 
et al., 2015). PEG is hydrophilic and not adhesive to proteins and 
cells; therefore, it requires blending with other natural polymers 
or functionalization with biochemical cues. It is possible to form 
strong robust hydrogels using PEG-based polymers. For instance, 
Hockaday et  al. (2012) printed aortic valve geometries using 
PEG-DA hydrogels blended with alginate and achieved 10-fold 
range in elastic modulus from ~5 to ~75 kPa. Hong et al. (2015) 
reported 3D printing of tough and biocompatible, cell-laden 
PEG–alginate–nanoclay hydrogels infused with collagen. Rutz 
et al. (2015) developed partially cross-linked PEG-based multi-
material bioink formulations with tunable viscosity to enhance 
print fidelity and secondary cross-linking ability to stabilize the 
constructs.
Alginate is one of the most commonly used natural polymers 
to formulate bioinks for inkjet and DIW printing. For inkjet 
printing, calcium chloride is jetted onto alginic acid solution 
(Boland et  al., 2007). For extrusion-based printing, alginate is 
printed as a viscous solution, and the constructs are exposed to 
CaCl2 solution to induce post-printing cross-linking. Alginate is 
not cell adhesive, thus it is generally blended with other natural 
polymers (e.g., gelatin and fibrinogen) to induce cell adhesion 
and biological activity (Xu et al., 2009; Jia et al., 2014; Yu et al., 
2014; Lim et  al., 2016; Pan et  al., 2016). Note that, the major-
ity of the natural polymers are used as a component of bioink 
formulation. HA and gelatin that have been utilized extensively 
in the form of functionalized polymers thus fall into the synthetic 
polymer category, which is discussed below.
Gelatin is commonly used in the form of gelatin methacry-
loyl (GelMA)-based hydrogel for DIW (Bertassoni et al., 2014; 
Loessner et al., 2016). Lim et al. (2016) recently reported a visible 
light photo-cross-linking system to minimize the oxygen inhi-
bition in photopolymerized GelMA hydrogels. They reported 
higher print fidelity and cell viability for ruthenium/sodium 
persulfate visible photo-initiator as compared to UV photo-
initiator Igracure 2959. Similar to gelatin, HA has been modified 
in many ways to create cell-laden bioinks (Highley et al., 2015; 
Rodell et al., 2015; Ouyang et al., 2016). For instance, Burdick 
lab reported HA-based supramolecular hydrogels cross-linked 
by cyclodextrin–adamantane host–guest interactions, which 
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are capable of shear-thinning and self-healing (Highley et al., 
2015). The non-covalent bonds allow direct writing of inks 
into support gels. HA hydrogels were developed to display 
both shear-thinning behavior due to guest–host bonding and 
stabilization post-printing via UV-induced covalent cross-
linking (Ouyang et  al., 2016). Supramolecular hydrogels are 
particularly attractive for extrusion-based printing as they 
could flow under shear and self-heal immediately after print-
ing, leading to high print fidelity. In addition to guest–host 
bonding, self-assembling peptides (Raphael et  al., 2017) and 
polypeptide–DNA hydrogels (Li et al., 2015) are other emerg-
ing candidates for bioink design.
Cell Suspension Bioinks
Modified inkjet printers have long been used to print cells into 
cellular assemblies. For instance, endothelial cells were printed 
from cell suspension (1 × 105 cells/ml) in growth media (Wilson 
and Boland, 2003a,b). Bioprinting of scaffold-free constructs 
utilizes cell aggregates in the form of mono- or multicellular 
spheroids as a bioink (Mironov et al., 2003; Norotte et al., 2009; 
Jakab et al., 2010; Christensen et al., 2015). The bioink formula-
tion undergoes a fully biological self-assembly without or in the 
presence of a temporary support layer (Norotte et al., 2009). This 
technique relies on tissue liquidity and fusion, which allow cells 
to self-assemble and fuse due to cell–cell interactions (Forgacs 
et al., 1998; Jakab et al., 2004; Fleming et al., 2010). For instance, 
Norotte et al. developed spheroids and cylinders of multicellular 
aggregates with controlled diameter in the range of 300–500 µm 
and showed that post-printing fusion led to single- and double-
layered vascular tubes. Organovo is the first medical research 
company that uses a similar approach to create functional human 
tissues toward in vitro disease models. The company has devel-
oped liver models using high density bioinks from parenchymal 
cells or non-parenchymal cells that are printed via extrusion-
based printing (Nguyen et  al., 2016). Tissues were allowed to 
mature in a bioreactor for at least 3  days to form scaffold-free 
tissues. Levato et  al. (2014) developed an alternative approach 
by combining bioprinting with microcarrier technology, which 
allowed extensive expansion of cells on cell-laden PLA-based 
microcarriers. Tan et al. (2016) used poly(d,l-lactic-co-glycolic 
acid) porous microspheres enabling cells to adhere and prolifer-
ate before printing.
deCM-Based Bioinks
Decellularized extracellular matrix-based bioinks involve decel-
lularization of a tissue of interest by removing the cells while pre-
serving the ECM. The ECM is then crushed into a powder form 
and dissolved in a cell friendly buffer solution to formulate the 
bioink. A carrier polymer could be used to increase the solubility, 
to tune the viscosity, or to induce/enhance post-cross-linking of 
the bioink. In this regard, Pati et al. (2014) printed 3D constructs 
using dECM-based bioinks supported by a PCL framework. 
For this purpose, dECM was obtained from fat, cartilage, and 
heart, using a combination of physical, enzymatic, and chemical 
processes. These ink materials were initially solubilized in an 
acidic buffer, and pH was adjusted to accommodate cells. This 
formulation was soluble at 10°C and gelled at 37°C. Following 
this study, the same group showed that the dECM bioink can 
be pre-gelled using vitamin B2-induced covalent cross-linking 
(Jang et al., 2016a,b,c). Using this approach, a 3D printed cardiac 
patch composed of multiple-cell lines including human cardiac 
progenitor cells and mesenchymal stem cells was developed 
(Jang et al., 2016a,b,c). Although dECM bioinks provide novel 
opportunities to fabricate tissue specific constructs, the decel-
lularization process requires multiple steps including precise 
quantification of the DNA and the ECM components, making it 
a costly approach.
SUMMARY AnD FUTURe PeRSPeCTiveS
3D printing has a strong potential to become a common fabrica-
tion technique in medicine as it enables fabrication of modular 
and patient-specific scaffolds and devices, and tissue models, 
with high structural complexity and design flexibility (Murphy 
and Atala, 2014; Jang et  al., 2016a,b,c; Kang et  al., 2016; Kuo 
et al., 2016; Zhang et al., 2016). There is a significant interest in 
designing novel bioink formulations toward the goal of achiev-
ing the “ideal” bioink for each bioprinting technology (Hölzl 
et al., 2016). Cell-laden hydrogels are the most common bioinks, 
offering novel strategies including multi-material printing, 
shear-thinning capability, and sequential cross-linking toward 
self-supporting constructs. dECM-based bioinks provide an 
alternative approach utilizing decellulerized tissues, yet the pro-
cessing of decellulerized tissue increases the cost of the bioinks. 
Cell aggregate printing enables direct printing of cells into tissue 
constructs, but the size of these constructs is currently limited 
as the process requires large quantities of cells. In addition to 
bioink development, there is also need for bioprinters with high 
resolution, which is particularly important to develop vascular-
ized constructs. Considering future perspectives, supramolecular 
hydrogels with reversible cross-linking mechanism (Rodell 
et al., 2015) and stimuli responsive materials for biomimetic 4D 
printing (Sydney Gladman et al., 2016) are potentially the most 
interesting candidates for bioink design. Finally, there are still 
many regulatory challenges to move the 3D bioprinted constructs 
into clinic.
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